These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19662309)

  • 1. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
    Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
    Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
    Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
    Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
    Hillard EA; Pigeon P; Vessières A; Amatore C; Jaouen G
    Dalton Trans; 2007 Nov; (43):5073-81. PubMed ID: 17992292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A series of unconjugated ferrocenyl phenols: prospects as anticancer agents.
    Hillard E; Vessières A; Le Bideau F; Plazuk D; Spera D; Huché M; Jaouen G
    ChemMedChem; 2006 May; 1(5):551-9. PubMed ID: 16892391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
    Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
    J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.
    Vessières A; Spera D; Top S; Misterkiewicz B; Heldt JM; Hillard E; Huché M; Plamont MA; Napolitano E; Fiaschi R; Jaouen G
    ChemMedChem; 2006 Nov; 1(11):1275-81. PubMed ID: 17022106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.
    Plazuk D; Top S; Vessières A; Plamont MA; Huché M; Zakrzewski J; Makal A; Woźniak K; Jaouen G
    Dalton Trans; 2010 Aug; 39(32):7444-50. PubMed ID: 20614088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer docking studies of cis and trans-η6-Cp*Rh-hydroxytamoxifen complexes at the estrogen, ERα and ERβ receptors, and growth inhibition to breast cancer cells.
    Top S; Efremenko I; Rager MN; Vessières A; Yaswen P; Jaouen G; Fish RH
    Inorg Chem; 2011 Jan; 50(1):271-84. PubMed ID: 21121684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.
    Top S; Kaloun el B; Vessières A; Leclercq G; Laïos I; Ourevitch M; Deuschel C; McGlinchey MJ; Jaouen G
    Chembiochem; 2003 Aug; 4(8):754-61. PubMed ID: 12898627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes.
    Gabano E; Cassino C; Bonetti S; Prandi C; Colangelo D; Ghiglia A; Osella D
    Org Biomol Chem; 2005 Oct; 3(19):3531-9. PubMed ID: 16172691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
    Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
    J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
    Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
    Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.
    Tan YL; Pigeon P; Hillard EA; Top S; Plamont MA; Vessières A; McGlinchey MJ; Müller-Bunz H; Jaouen G
    Dalton Trans; 2009 Dec; (48):10871-81. PubMed ID: 20023917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.
    Top S; Vessières A; Pigeon P; Rager MN; Huché M; Salomon E; Cabestaing C; Vaissermann J; Jaouen G
    Chembiochem; 2004 Aug; 5(8):1104-13. PubMed ID: 15300835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of unique 17beta-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines.
    Bérubé G; Rabouin D; Perron V; N'Zemba B; Gaudreault RC; Parent S; Asselin E
    Steroids; 2006 Oct; 71(10):911-21. PubMed ID: 16914177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
    Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
    J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.